Aptevo Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $-5.9M | $35.0M |
| Jun 2022 | — | $23.0M | $29.4M |
| Sep 2022 | $1.9M | $15.8M | $22.2M |
| Dec 2022 | $1.5M | $18.0M | $22.6M |
| Mar 2023 | $0 | $23.3M | $25.3M |
| Jun 2023 | $0 | $16.3M | $21.0M |
| Sep 2023 | $0 | $14.7M | $19.1M |
| Dec 2023 | $0 | $12.2M | $16.9M |
| Mar 2024 | — | $6.1M | $10.3M |
| Jun 2024 | — | $4.5M | $8.1M |
| Sep 2024 | — | $4.4M | $7.8M |
| Dec 2024 | — | $4.8M | $8.7M |
| Mar 2025 | — | $-1.5M | $2.1M |
| Jun 2025 | — | $6.5M | $9.4M |
| Sep 2025 | — | $17.4M | $21.1M |
| Dec 2025 | — | $17.4M | $21.6M |
| Mar 2026 | — | $11.6M | $14.5M |
| Jun 2026 | — | $6.0M | $9.8M |